107 related articles for article (PubMed ID: 27038444)
1. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.
Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D
J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
[TBL] [Abstract][Full Text] [Related]
3. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
4. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
[TBL] [Abstract][Full Text] [Related]
5. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
6. Serum galectin-3 as a potential marker for gastric cancer.
Cheng D; Liang B; Li Y
Med Sci Monit; 2015 Mar; 21():755-60. PubMed ID: 25765552
[TBL] [Abstract][Full Text] [Related]
7. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
Erturk K; Tastekin D; Bilgin E; Serilmez M; Bozbey HU; Sakar B
Biomed Pharmacother; 2016 Feb; 77():86-91. PubMed ID: 26796270
[TBL] [Abstract][Full Text] [Related]
8. [Study on the expression and significance of Galectin-3 and CDC25B mRNA in human gastric carcinoma].
Zhang XM; Yao GY; Zhang BY; Wang LL; Zhao M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):288-92. PubMed ID: 19504441
[TBL] [Abstract][Full Text] [Related]
9. [Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer].
Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):151-4. PubMed ID: 16155829
[TBL] [Abstract][Full Text] [Related]
10. [Expression of galectin-3 mRNA in gastric cancer with peritoneal metastasis].
Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):105-8. PubMed ID: 16468655
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
12. Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer.
Dong WG; Yu QF; Xu Y; Fan LF
Dig Dis Sci; 2008 Jul; 53(7):1811-7. PubMed ID: 17999183
[TBL] [Abstract][Full Text] [Related]
13. Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer.
Yang J; Zhu L; Cai Y; Suo J; Jin J
Int J Oncol; 2014 Sep; 45(3):1313-20. PubMed ID: 24919464
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum caveolin-1 levels in melanoma patients.
Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D
Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Mar; 70():19-23. PubMed ID: 25776473
[TBL] [Abstract][Full Text] [Related]
16. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
Tas F; Bilgin E; Karabulut S; Duranyildiz D
Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.
Chang CC; Sun CF; Pai HJ; Wang WK; Hsieh CC; Kuo LM; Wang CS
Chang Gung Med J; 2010; 33(3):301-12. PubMed ID: 20584508
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.
Erturk K; Tastekin D; Serilmez M; Bilgin E; Bozbey HU; Vatansever S
Tumour Biol; 2016 Jan; 37(1):405-12. PubMed ID: 26219901
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression.
Kim SJ; Choi IJ; Cheong TC; Lee SJ; Lotan R; Park SH; Chun KH
Gastroenterology; 2010 Mar; 138(3):1035-45.e1-2. PubMed ID: 19818782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
